CA
NZ
UK
AU
IND
US
AMN Healthcare Services Inc (NYSE:AMN) has been attracting fresh analyst commentary as investors assess a stronger-than-expected outlook for the healthcare staffing market. The company has a market capitalisation of about $1.41 billion, and several brokers have lifted price targets in recent weeks, including BMO …
Adlai Nortye Group Ltd. (NASDAQ:ANL), a clinical-stage oncology company, has had a busy autumn, dosing the first patient in a new antibody-drug conjugate trial and strengthening its cash position through two private placements earlier in the year. The company has a market capitalisation of …
● A semiconductor-led selloff pushed investors toward value, energy and defensive healthcare.
● No company-specific catalyst has been tied to the advance.
● Molina is a managed-care organization built largely around Medicaid and related plans.
● Passage Bio is a clinical-stage gene-therapy company at the speculative end of biotech.
● Investors pivoted away from high-momentum technology toward value, energy and healthcare.
● Processa is a clinical-stage biotechnology company trading at a low share price.
● The small-cap medical-device name was among the day's notable gainers.
● A gain above 30% is sharp but not unusual for a low-priced clinical-stage biotech.
Please wait processing your request...